NORETHINDRONE AND ETHINYL ESTRADIOL

N/A

Manufactured by Teva Pharmaceuticals USA, Inc.

2,014 FDA adverse event reports analyzed

Last updated: 2026-04-15

About NORETHINDRONE AND ETHINYL ESTRADIOL

NORETHINDRONE AND ETHINYL ESTRADIOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Teva Pharmaceuticals USA, Inc.. The most commonly reported adverse reactions for NORETHINDRONE AND ETHINYL ESTRADIOL include NAUSEA, HEADACHE, FATIGUE, DRUG INEFFECTIVE, VOMITING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for NORETHINDRONE AND ETHINYL ESTRADIOL.

Top Adverse Reactions

NAUSEA108 reports
HEADACHE81 reports
FATIGUE58 reports
DRUG INEFFECTIVE53 reports
VOMITING48 reports
PAIN47 reports
DIZZINESS45 reports
DIARRHOEA43 reports
ANXIETY42 reports
RASH40 reports
PULMONARY EMBOLISM37 reports
ABDOMINAL PAIN31 reports
INSOMNIA31 reports
WEIGHT INCREASED31 reports
FEELING ABNORMAL30 reports
DEPRESSION29 reports
ASTHENIA27 reports
MALAISE27 reports
MIGRAINE24 reports
DYSPNOEA23 reports
MUSCLE SPASMS23 reports
PAIN IN EXTREMITY23 reports
PRURITUS23 reports
DEEP VEIN THROMBOSIS22 reports
FLUSHING22 reports
METRORRHAGIA22 reports
PARAESTHESIA22 reports
ARTHRALGIA21 reports
CONDITION AGGRAVATED21 reports
HYPOAESTHESIA21 reports
OFF LABEL USE21 reports
PRODUCT SUBSTITUTION ISSUE20 reports
PRODUCT USE IN UNAPPROVED INDICATION20 reports
URTICARIA20 reports
VAGINAL HAEMORRHAGE20 reports
INJECTION SITE PAIN19 reports
PRODUCT DOSE OMISSION ISSUE19 reports
FALL18 reports
HYPERHIDROSIS18 reports
HYPERSENSITIVITY18 reports
NASOPHARYNGITIS18 reports
TREMOR18 reports
CONSTIPATION16 reports
EXPOSURE DURING PREGNANCY16 reports
SOMNOLENCE16 reports
ABDOMINAL DISCOMFORT15 reports
ABDOMINAL DISTENSION15 reports
BACK PAIN15 reports
COUGH15 reports
FEELING HOT15 reports
INJECTION SITE ERYTHEMA15 reports
INJURY15 reports
THROMBOSIS15 reports
CROHN^S DISEASE14 reports
DECREASED APPETITE14 reports
DEHYDRATION14 reports
PRODUCT DOSE OMISSION14 reports
PRODUCT USE ISSUE14 reports
ABDOMINAL PAIN UPPER13 reports
BALANCE DISORDER13 reports
CHEST PAIN13 reports
DYSMENORRHOEA13 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION13 reports
NO ADVERSE EVENT13 reports
PALPITATIONS13 reports
SINUSITIS13 reports
ACNE12 reports
CHOLECYSTITIS CHRONIC12 reports
COELIAC DISEASE12 reports
DRUG DOSE OMISSION12 reports
GAIT DISTURBANCE12 reports
MENSTRUAL DISORDER12 reports
PRODUCT QUALITY ISSUE12 reports
WEIGHT DECREASED12 reports
ALOPECIA11 reports
DYSPHAGIA11 reports
EMOTIONAL DISTRESS11 reports
GASTROOESOPHAGEAL REFLUX DISEASE11 reports
INJECTION SITE BRUISING11 reports
MENORRHAGIA11 reports
MENSTRUATION IRREGULAR11 reports
MYALGIA11 reports
PYREXIA11 reports
UNEVALUABLE EVENT11 reports
URINARY TRACT INFECTION11 reports
VISUAL IMPAIRMENT11 reports
CHOLELITHIASIS10 reports
ERYTHEMA10 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION10 reports
INCORRECT DOSE ADMINISTERED10 reports
INFLUENZA LIKE ILLNESS10 reports
INJECTION SITE PRURITUS10 reports
MULTIPLE SCLEROSIS RELAPSE10 reports
OROPHARYNGEAL PAIN10 reports
PSORIASIS10 reports
SLEEP DISORDER10 reports
STRESS10 reports
SWOLLEN TONGUE10 reports
SYNCOPE10 reports
THERAPY CESSATION10 reports

Report Outcomes

Out of 1,115 classified reports for NORETHINDRONE AND ETHINYL ESTRADIOL:

Serious 43.8%Non-Serious 56.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,000 (98.8%)
Male9 (0.9%)
Unknown3 (0.3%)

Reports by Age

Age 3429 reports
Age 3326 reports
Age 4425 reports
Age 3724 reports
Age 2923 reports
Age 3122 reports
Age 3222 reports
Age 2021 reports
Age 2521 reports
Age 3021 reports
Age 3621 reports
Age 4319 reports
Age 2218 reports
Age 2317 reports
Age 2717 reports
Age 2816 reports
Age 4616 reports
Age 2615 reports
Age 3515 reports
Age 4015 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with NORETHINDRONE AND ETHINYL ESTRADIOL?

This profile reflects 2,014 FDA FAERS reports that mention NORETHINDRONE AND ETHINYL ESTRADIOL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for NORETHINDRONE AND ETHINYL ESTRADIOL?

Frequently reported terms in FAERS include NAUSEA, HEADACHE, FATIGUE, DRUG INEFFECTIVE, VOMITING, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures NORETHINDRONE AND ETHINYL ESTRADIOL?

Labeling and FAERS entries often list Teva Pharmaceuticals USA, Inc. in connection with NORETHINDRONE AND ETHINYL ESTRADIOL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.